Supersensitivity psychosis. The particularity of clozapine;Notion de psychose d'hypersensibilite cas particulier de la clozapine

Encephale

Volumn 25, Issue 6, 1999, Pages 638-644

  Llorca, P M ^a   Penault, F ^a   Lancon C ^b   Dufumier, E ^a   Vaiva, G ^c  

^a CH Sainte Marie   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Clozapine; Resistance; Supersensitivity psychosis; Tolerance

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; HUMAN; MALE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REBOUND; SCHIZOPHRENIA; SUPERSENSITIVITY; SUPERSENSITIVITY PSYCHOSIS; TARDIVE DYSKINESIA;

ADULT; ANTIPSYCHOTIC AGENTS; CATATONIA; CLOZAPINE; DISSOCIATIVE DISORDERS; DRUG TOLERANCE; HUMANS; MALE; PSYCHOMOTOR DISORDERS; PSYCHOSES, SUBSTANCE-INDUCED; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033393230     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ALPHS LD, LEE HS. Comparison of withdrawal of typical and atypical antipsychotic drugs : a case study. J Clin Psy 1991 ; 52 : 346-8.
2. BORISON RL, DIAMOND BI, DHARMBEER S et al. Clozapine rebond psychosis. Psychopharmacol Bull 1988 ; 24 : 260-3.
3. BURT DR, CREESE I, SNYDER SH. Antischizophrenic drugs : chronic treatment elevates dopamine receptor binding in brain. Science 1977 ; 196 : 326-8.
4. CHOUINARD G, ANNABLE L, ROSS-CHOUINARD A et al. A five year prospective longitudinal study of tardive dyskinesia : factors predicting appearance of new cases. J Clin Psychopharmacol 1988 ; 8 : 21S-6.
5. CHOUINARD G, ANNABLE L, ROSS-CHOUINARD A et al. A ten-year follow-up study of supersensitivity psychosis. Biol Psy 1990 ; 27: 140 A.
6. CHOUINARD G, BRADWEIN J. Reversible and irreversible tardive dyskinesia : a case report. Am J Psy 1982 ; 139 : 360-2.
7. CHOUINARD G, JONES BD. Neuroleptic induced supersensitivity psychosis : clinical and pharmacological characteristics. Am J Psy 1980 ; 137 : 16-21.
8. CHOUINARD G, JONES BD. Schizophrenia as dopamine deficiency disease. Lancet 1978 ; 2 : 99-100.
9. CHOUINARD G, JONES BD, ANNABLE L. Neuroleptic induced supersensitivity psychosis. Am J Psy 1978 ; 135 : 1409-10.
10. DE LEON J, STANILLA JK, WHITE AO et al. Anticholinergics to treat clozapine withdrawal. J Clin Psy 1994 ; 55 : 119-20.
11. EKBLOM B, ERIKSSON K, LINDSTROM LH. SSP in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology 1984; 83 : 293-4.
12. GILBERT PL, HARRIS MJ, McADAMS LA et al. Neuroleptic withdrawal in schizophrenic patients : a review of the literature. Arch Gen Psy 1995 ; 52 : 173-88.
13. ICHIKAWA J, MELTZER HY. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. J Pharmacol Exp Ther 1991 ; 256 : 348-57.
14. KANE J, HONIGFELD G, SINGER J et al. Clozapine for the treatment-resistant schizophrenics : a double-blind comparison versus chlorpromazine/benztropine. Arch Gen Psy 1988 ; 45 : 789-96.
15. KUHA S. The consequences of sudden stopping of clozapine in Finland. American Psychiatric Association, Abstracts 1977 ; 813 : 153.
16. MILLER R, CHOUINARD G. Loss of striatal cholinergic neurons as a basis for tardive and L-Dopa induced tardive dyskinesia, neuroleptic induced supersensitivity psychosis and refractory schizophrenia. Biol Psy 1993 ; 34 : 713-38.
17. N'GUYEN JA, THAKER GK, TAMMINGA CA. Gamma amino butyric acid pathways in tardive dyskinesia. Psychiatric Annals 1989 ; 19 : 302-9.
18. OWEN RR, BEAKE BJ, MARBY D et al. Response to clozapine in chronic psychotic patients. Psychopharmacol Bull 1989 ; 25 : 253-6.
19. PETIT M. Résistance : approche pharmacoclinique. Rueil-Malmaison : Sandoz éditions, Cahier du Prisme, 1992 ; 3 : 23-33.
20. SCHULTZ SK, MILLER DD, ARNDT S et al. Withdrawal emergent dyskinesia in patient with schizophrenia during antipsychotic discontinuation. Biol Psy 1995 ; 38 : 713-9.
21. SEEGER T, GARDNER E. Enhancement of self-stimulation in rats and monkeys after chronic neuroleptic treatments : evidence for mesolimbic sensitivity. Brain Research 1979 ; 175 : 49-57.
22. STEINER W, LAPORTA M, CHOUINARD G. Neuroleptic induced SSP in patients with bipolar affective disorders. Act Psy Scand 1990 ; 81 : 437-40.
23. VERGHESE C, DE LEON J, NAIR C et al. Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics. Biol Psy 1996 ; 39: 135-8.